Status:
COMPLETED
Associations of Plasma Vanadium Concentrations With Gestational Diabetes Mellitus
Lead Sponsor:
Liegang Liu
Conditions:
Gestational Diabetes
Eligibility:
FEMALE
20-43 years
Brief Summary
Background: Vanadium compounds have been shown to exert insulin-mimetic effects and thereby control glucose homeostasis. However, studies regarding the levels of vanadium and gestational diabetes mell...
Eligibility Criteria
Inclusion
- Age ≥ 20 and ≤ 43 years;
- Gestational age at GDM screening ≥ 24 weeks;
- Singleton pregnancy;
Exclusion
- History of diabetes (including but not limited to GDM), cardiovascular disease, cancer or other systemic diseases;
- History of receiving pharmacological treatment known to affect glucose metabolism;
- Incomplete basic information.
Key Trial Info
Start Date :
August 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
504 Patients enrolled
Trial Details
Trial ID
NCT05267457
Start Date
August 1 2012
End Date
June 30 2020
Last Update
March 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.